Literature DB >> 19074907

Epithelial-mesenchymal transition induced by growth suppressor p12CDK2-AP1 promotes tumor cell local invasion but suppresses distant colony growth.

Takanori Tsuji1, Soichiro Ibaragi, Kaori Shima, Miaofen G Hu, Miki Katsurano, Akira Sasaki, Guo-fu Hu.   

Abstract

Epithelial-mesenchymal transition (EMT) has been considered essential for metastasis, a multistep process including local invasion, intravasation, extravasation, and proliferation at distant sites. However, controversy remains as to whether EMT truly happens and how important it is to metastasis. We studied the involvement of EMT in individual steps of metastasis and found that p12(CDK2-AP1), a down-stream effector of transforming growth factor beta, induced EMT of hamster cheek pouch carcinoma-1 cells by promoting the expression of Twist2. EMT cells have an increased invasive but decreased metastatic phenotype. When s.c. inoculated, both EMT and non-EMT cells established primary tumors, but only EMT cells invaded into the adjacent tissues and blood vessels; however, neither cells formed lung metastases. When i.v. inoculated, only non-EMT cells established lung metastases. Moreover, s.c. inoculation of a mixture of the two cell types resulted in intravasation of both cell types and formation of lung metastasis from non-EMT cells. Our results allowed us to propose a novel model for the role of EMT in cancer metastasis. We showed that EMT and non-EMT cells cooperate to complete the spontaneous metastasis process. We thus hypothesize that EMT cells are responsible for degrading the surrounding matrix to lead the way of invasion and intravasation. Non-EMT cells then enter the blood stream and reestablish colonies in the secondary sites.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074907      PMCID: PMC2605670          DOI: 10.1158/0008-5472.CAN-08-1444

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein.

Authors:  S Shintani; H Ohyama; X Zhang; J McBride; K Matsuo; T Tsuji; M G Hu; G Hu; Y Kohno; M Lerman; R Todd; D T Wong
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

3.  The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells.

Authors:  E Batlle; E Sancho; C Francí; D Domínguez; M Monfar; J Baulida; A García De Herreros
Journal:  Nat Cell Biol       Date:  2000-02       Impact factor: 28.824

4.  The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion.

Authors:  J Comijn; G Berx; P Vermassen; K Verschueren; L van Grunsven; E Bruyneel; M Mareel; D Huylebroeck; F van Roy
Journal:  Mol Cell       Date:  2001-06       Impact factor: 17.970

5.  Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments].

Authors:  I K Bukholm; J M Nesland; A L Børresen-Dale
Journal:  J Pathol       Date:  2000-01       Impact factor: 7.996

6.  A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions.

Authors:  M A Perez-Moreno; A Locascio; I Rodrigo; G Dhondt; F Portillo; M A Nieto; A Cano
Journal:  J Biol Chem       Date:  2001-04-17       Impact factor: 5.157

7.  p12(DOC-1), a growth suppressor, associates with DNA polymerase alpha/primase.

Authors:  K Matsuo; S Shintani; T Tsuji; E Nagata; M Lerman; J McBride; Y Nakahara; H Ohyama; R Todd; D T Wong
Journal:  FASEB J       Date:  2000-07       Impact factor: 5.191

8.  The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation.

Authors:  A Jung; M Schrauder; U Oswald; C Knoll; P Sellberg; R Palmqvist; G Niedobitek; T Brabletz; T Kirchner
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

9.  Alterations of the 16q22.1 and 16q24.3 chromosomal loci in sporadic invasive breast carcinomas: correlation with proliferative activity, ploidy and hormonal status of the tumors.

Authors:  M Kouvaraki; V G Gorgoulis; G Z Rassidakis; P Liodis; E Koutroumbi; C Markopoulos; J Gogas; C Kittas
Journal:  Anticancer Res       Date:  2001 Mar-Apr       Impact factor: 2.480

Review 10.  Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer.

Authors:  Geert Berx; Eric Raspé; Gerhard Christofori; Jean Paul Thiery; Jonathan P Sleeman
Journal:  Clin Exp Metastasis       Date:  2007-11-03       Impact factor: 5.150

View more
  122 in total

Review 1.  Materials and microfluidics: enabling the efficient isolation and analysis of circulating tumour cells.

Authors:  Joshua M Jackson; Małgorzata A Witek; Joyce W Kamande; Steven A Soper
Journal:  Chem Soc Rev       Date:  2017-07-17       Impact factor: 54.564

Review 2.  Challenges in circulating tumour cell research.

Authors:  Catherine Alix-Panabières; Klaus Pantel
Journal:  Nat Rev Cancer       Date:  2014-07-31       Impact factor: 60.716

3.  Small cell lung cancer: Circulating tumor cells of extended stage patients express a mesenchymal-epithelial transition phenotype.

Authors:  Gerhard Hamilton; Maximilian Hochmair; Barbara Rath; Lukas Klameth; Robert Zeillinger
Journal:  Cell Adh Migr       Date:  2016-02-26       Impact factor: 3.405

Review 4.  Tumor metastasis: moving new biological insights into the clinic.

Authors:  Liling Wan; Klaus Pantel; Yibin Kang
Journal:  Nat Med       Date:  2013-11       Impact factor: 53.440

5.  Progesterone is primary regulator of Cdk2ap1 gene expression and tissue-specific expression in the uterus.

Authors:  Y P Cheon; C H Kim
Journal:  J Endocrinol Invest       Date:  2010-03-30       Impact factor: 4.256

Review 6.  Defining the Hallmarks of Metastasis.

Authors:  Danny R Welch; Douglas R Hurst
Journal:  Cancer Res       Date:  2019-05-03       Impact factor: 12.701

Review 7.  Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.

Authors:  Deepika Neelakantan; David J Drasin; Heide L Ford
Journal:  Cell Adh Migr       Date:  2014-10-16       Impact factor: 3.405

Review 8.  Challenges and unanswered questions for the next decade of circulating tumour cell research in lung cancer.

Authors:  Sumitra Mohan; Francesca Chemi; Ged Brady
Journal:  Transl Lung Cancer Res       Date:  2017-08

Review 9.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

10.  Down-regualtion of miR-106b induces epithelial-mesenchymal transition but suppresses metastatic colonization by targeting Prrx1 in colorectal cancer.

Authors:  Lin Zheng; Yuqin Zhang; Shuimiao Lin; Aimin Sun; Runze Chen; Yi Ding; Yanqing Ding
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.